Norges Bank’s PDL BioPharma, Inc. PDLI Stock Holding History

Norges Bank’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,373,360	Closed	-$3.76M	–	2202
2017 Q4	$3.76M	Buy	1,373,360 +104,701	+8%	+$322K	﹤0.01%	1907
2017 Q3	$4.3M	Sell	1,268,659 -358,416	-22%	-$997K	﹤0.01%	1887
2017 Q2	$4.02M	Sell	1,627,075 -315,000	-16%	-$725K	﹤0.01%	1919
2017 Q1	$4.41M	Sell	1,942,075 -448,430	-19%	-$992K	﹤0.01%	1906
2016 Q4	$5.07M	Buy	2,390,505 +264,517	+12%	+$738K	﹤0.01%	1859
2016 Q3	$6.8M	Buy	2,125,988 +302,500	+17%	+$960K	﹤0.01%	1802
2016 Q2	$5.73M	Buy	1,823,488 +735,442	+68%	+$2.45M	﹤0.01%	1839
2016 Q1	$3.62M	Buy	1,088,046 +137,000	+14%	+$427K	﹤0.01%	1915
2015 Q4	$3.37M	Sell	951,046 -494,074	-34%	-$2.07M	﹤0.01%	1949
2015 Q3	$7.27M	Buy	1,445,120 +149,403	+12%	+$856K	﹤0.01%	1728
2015 Q2	$8.33M	Hold	1,295,717	–	–	﹤0.01%	1723
2015 Q1	$9.12M	Sell	1,295,717 -115,413	-8%	-$836K	﹤0.01%	1685
2014 Q4	$10.9M	Sell	1,411,130 -303,264	-18%	-$2.4M	0.01%	1597
2014 Q3	$12.8M	Sell	1,714,394 -1,714,394	-50%	-$15.9M	0.01%	1432
2014 Q2	$33.2M	Buy	3,428,788 +2,359,352	+221%	+$21M	0.01%	1282
2014 Q1	$8.89M	Hold	1,069,436	–	–	0.01%	1639
2013 Q4	$9.03M	Hold	1,069,436	–	–	0.01%	1630
2013 Q3	$8.52M	Buy	1,069,436 +375,736	+54%	+$3.02M	0.01%	1648
2013 Q2	$5.36M	Buy	+693,700	New	+$5.41M	﹤0.01%	1810

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Norges Bank's PDLI Position: Q1 2018 in Review

Norges Bank sold out of PDL BioPharma, Inc. (PDLI) in Q1 2018, closing a stake of 1,373,360 shares — an estimated $3.76M sold.

Norges Bank first reported a position in PDLI in Q2 2013 and held it in 19 quarters. The position peaked at $33.2M in Q2 2014. 176 funds tracked by Wall St. Rank hold PDLI as of Q1 2018.

Norges Bank reported no remaining PDL BioPharma, Inc. position as of Q1 2018 after selling out during the quarter.
Norges Bank sold 1,373,360 PDL BioPharma, Inc. shares in Q1 2018, an estimated $3.76M.
Norges Bank first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 19 quarters.
Norges Bank's PDL BioPharma, Inc. position peaked at $33.2M in Q2 2014.
176 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2018.

Based on Norges Bank's 13F filing for Q1 2018, filed 9 May 2018.